Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Vaccine confidence volatile, vulnerable to misinformation, global study finds

Published 10/09/2020, 23:41
Updated 10/09/2020, 23:45
© Reuters. FILE PHOTO: Robyn Porteous, a vaccine trials' volunteer, is injected as part of the country's human clinical trial for potential vaccines after being tested for the coronavirus disease (COVID-19), at the Wits RHI Shandukani Research Centre in Jo

By Kate Kelland

LONDON (Reuters) - Political polarisation and online misinformation are threatening vaccination programmes worldwide, with public trust volatile and varying widely between countries, according to a global vaccine confidence study.

The study, which maps trends in vaccine confidence across 149 countries between 2015 and 2019, found that scepticism about the safety of vaccines tended to grow alongside political instability and religious extremism.

"It is vital with new and emerging disease threats such as the COVID-19 pandemic, that we regularly monitor public attitudes," said Heidi Larson, a professor at the London school of Hygiene & Tropical Medicine who led the research.

"Perceptions about vaccines are much more volatile than they used to be," she told a briefing. "Overall, there's a lot of confidence in the world about vaccines. But don't take it for granted. Confidence goes up and down ... it's highly variable."

Published in the Lancet medical journal, Larson's findings are based on data from more than 284,000 adults asked in 2019 whether they see vaccines as important, safe and effective.

Larson said that with drugmakers and researchers around the world racing to develop vaccines against the COVID-19 pandemic, governments should be now be extra vigilant about assessing public trust in vaccines and responding rapidly to concerns.

"There's a lot of anxiety about the speed of vaccine development (for COVID-19)," she said. "But the public is not really keen on speed - they're more keen on thoroughness, effectiveness and safety."

The study's results show that vaccine confidence in Europe is low compared to other regions of the world, such as Africa, with the proportion of people strongly agreeing that vaccines are safe ranging from 19% in Lithuania to 66% in Finland.

Iraq, Liberia and Senegal had the highest proportion of respondents in 2019 who agreed vaccines are important.

But public trust in vaccines has risen in some European countries since 2015, including France, Italy, Ireland and Britain.

The study found six countries where vaccine confidence had dropped significantly since 2015.

In Indonesia, Pakistan, Serbia, Azerbaijan, Afghanistan and Nigeria, the proportion of people strongly disagreeing that vaccines are safe had increased significantly. This, Larson said, was linked to trends in political instability and religious extremism in these countries.

"Among some countries, there is more polarisation of sentiment. More people are going to the extremes of 'strongly disagree' or 'strongly agree'," she said.

© Reuters. FILE PHOTO: Robyn Porteous, a vaccine trials' volunteer, is injected as part of the country's human clinical trial for potential vaccines after being tested for the coronavirus disease (COVID-19), at the Wits RHI Shandukani Research Centre in Johannesburg

Indonesia saw one of the largest falls in public trust worldwide between 2015 and 2019, triggered in part by Muslim leaders questioning the measles, mumps, and rubella vaccine, and by local healers promoting natural alternatives to vaccines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.